NAFLD is one of the most important causes of liver disease worldwide and will probably
emerge as the leading cause of end-stage liver disease in the coming decades, with the …

Nonalcoholic fatty liver disease (NAFLD) affects 25% of the global adult population with a
range of 13.5% in Africa and 31.8% in the Middle East. Nonalcoholic fatty liver disease is …

This review of the literature consists of three sections. First, papers concerning non-alcoholic
fatty liver disease (NAFLD) awareness among the general population, general practitioners …

OBJECTIVE Only a few studies have evaluated the long-term effects of nonalcoholic fatty
liver disease (NAFLD) on type 2 diabetes mellitus (T2DM), and none have examined …

OBJECTIVE To describe associations between alcoholic liver disease (ALD) or nonalcoholic
fatty liver disease (NAFLD) hospital admission and cardiovascular disease (CVD), cancer …

Alcoholic liver disease (ALD), a disorder caused by excessive alcohol consumption is a
global health issue. More than two billion people consume alcohol in the world and about 75 …

Aim Although essential phospholipids (EPL) from soybean are often used in membrane-
associated disorders and diseases, their high quality of purification and effects on prevalent …

We provide a concise review of the main epidemiological literature on fatty liver (FL)
published between January 2011 and October 2013. The findings from the literature will be …

The high prevalence of non‐alcoholic fatty liver disease (NAFLD) has made the condition an
important public health issue. Two clinical entities are manifestations of NAFLD, namely, non …

Fatty liver disease is epidemiologically associated with type 2 diabetes (T2D), leading to a
speculation of a reciprocal cause–effect relationship and a vicious cycle of pathology. Here …